Erasca

Precision Medicine · Oncology Therapeutics
4open roles
$355kmedian advertised pay
Scaling fasthiring pace, 79 of 100
48 daysmedian time a role stays open

Overview

Erasca is a clinical-stage biopharmaceutical company developing precision oncology drugs. Its programs target the RAS/MAPK signalling pathway, which is often mutated in cancers such as pancreatic, lung and colorectal cancer. The company was founded in 2018 and is headquartered in San Diego, California, United States.

How Erasca hires

Truth index
B 75/100
Median time to fill
48 days
Ghost roles
0%
Stale roles
100%
Reposted roles
0%

Erasca scores B on the Alion truth index (A is best, E worst), measured over 3 open roles re-checked against its own hiring board: 0% look like ghost listings, 100% have gone stale and 0% are the same role posted again. Its roles close in a median of 48 days. It measures how much of what this employer publishes turns into a real, finite search - not the employer as a workplace. How the index is computed

Jobs

$275k – $355k per year · Equity · Remote (United States) · 10+ years exp · PhD · San Diego · South San Francisco
Apply
$185k – $200k per year · Equity · Remote (United States) · 6+ years exp · PhD · San Diego · South San Francisco
Smartsheet
Apply
$145k – $190k per year · Equity · Remote (United States) · 7+ years exp · PhD · San Diego
Good Clinical Practice
Apply
$390k – $435k per year · Equity · Remote (United States) · PhD · San Diego · South San Francisco
Apply

Salary insights

Compensation ranges based on this company's open jobs
Median
$355k
Typical range
$190k – $435k
Open positions
5
5 Jobs
Senior 40%
Staff 20%
Architect 40%
Level Jobs Median Typical range
Senior 2 $195k $190k – $200k
Staff 1 $435k $435k
Architect 2 $385k $355k – $415k
Highest paying role SVP Clinical Development & Global Program Lead, Pancreatic Cancer $435k
Normalized to USD per year
All salaries at Erasca By role, level and city, against the market · 5 jobs with pay

Growth

Hiring Momentum
79/100
Scaling fast
Open positions
5
2 opened / 2 closed in 30 days
Median time-to-fill
55 days
faster than 24% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics +100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Early Careers
43% ▼
Biotech
29% ▲
Administrative
14% ▼
Industrial Engineering
14% ▼
Activity Timeline
Added CDISC to stack Oct 2026
Added GMP to stack Oct 2026
Added Good Clinical Practice to stack Oct 2026
Added Smartsheet to stack Oct 2026
Added CAPA to stack Oct 2026
New location: South San Francisco Sep 2026
Added Microsoft Office to stack Sep 2026

People

Jonathan Lim M.D.
Executive Officer, Director
Gary Yeung CFA
Executive Officer
Pratik Multani M.D.
Director
Valerie Harding-Start
Director
Alexander Casdin
Director
James Bristol Ph.D.
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Tech stack

Technologies named in job postings at Erasca over the last 12 months, by layer, with the share of postings for each.
Technologies in use
7
Postings analysed
5
Stack modernity
49/100
Languages
SAS
Cloud & platforms
GCP
Developer tools
Mandiant capa
Practices & domains
CAPA
CDISC
GMP
Good Clinical Practice
Sign in to see how your skills match this stack Sign In

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors2
126 portfolio companies: Vilya, Xaira Therapeutics, Vizgen and 123 more
857 portfolio companies

News

News YahooFinance 2 months ago
FDA Fast Track Puts Erasca's (ERAS) Pancreatic Bet Center Stage
On August 24, Erasca (NASDAQ:ERAS) announced that the FDA had granted Fast Track Designation to ERAS-0015, its oral pan-RAS molecular glue, for patients with metastatic pancreatic adenocarcinoma. The designation gives Erasca more frequent contact with reg
Read more
Report
Press release businesswire 4 months ago
Erasca, Inc. Class Action Reminder - Robbins LLP Encourages ERAS Stockholders to Contact the Firm for Information About Their Rights
Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Erasca, Inc. (NASDAQ: ERAS) sec...
Read more
Report
Press release The Globe and Mail 4 months ago
Erasca Announces Proposed Public Offering of $500 Million of Common Stock
Detailed price information for Erasca Inc (ERAS-Q) from The Globe and Mail including charting and trades.
Read more
Report
Press release The Globe and Mail 6 months ago
Erasca Stock Is Up 715%. Here's Why One Biotech Fund Still Bought $68 Million More
Detailed price information for Erasca Inc (ERAS-Q) from The Globe and Mail including charting and trades.
Read more
Report
News Erasca 5 years ago
Erasca Raises $200 Million Series B Financing
Proceeds to advance lead programs into the clinic and fund robust pipeline of oncology therapies Financing round co-led by ARCH Venture Partners and Cormorant Asset Management SAN DIEGO, April 27, 2020 - Erasca, a company whose mission is to erase cancer,
Read more
Report

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
2
Countries
1
Busiest office
San Diego
Loading the map
Headquarters Builds here Office with open vacancies Tap a pin for the office
San Diego United States
HQ
Contact Us
5 open roles 8 posted in 90 days 100% remote 50-200 est. staff $319k Avg Salary
hires for Biotech, Early Careers
Suite 300, San Diego, California 92121
seen since May 2026 company site, careers board, job postings
South San Francisco United States
Remote hub
Gateway
4 open roles 6 posted in 90 days 100% remote 10-50 est. staff $351k Avg Salary
hires for Early Careers, Biotech
seen since May 2026 careers board